ADVERTISEMENT

ESMO 2022 – Is immunotherapy changing the standard of care in endometrial and cervical cancers?

Daniela Ovadia — Agenzia Zoe   |   Conference Report   |   12 September 2022
ADVERTISEMENT

Immunotherapy could be a game changer for endometrial and cervical cancers but with some restrictions. The topic was discussed at ESMO 2022 .

 

Endometrial cancer

"Endometrial cancer (EC) remains the only gynaecological malignancy with rising incidence and mortality" said Domenica Lorusso, from Fondazione Policlinico Universitario Gemelli in Rome (Italy)....

          

September Challenge

Ends in 7d 4h
left
right

Topic Challenges

left
right